Zanjan University of Medical Sciences پست الكترونيك · درباره دانشگاه · اخبار دانشگاه · نقشه پايگاه · كتابخانه · English
شناسه کاربری رمز عبور ثبت نام در پایگاه | فراموشی رمز
بخش‌های اصلی
صفحه اصلی::
معاونت تحقیقات و فناوری::
معرفی::
کتابخانه مرکزی::
کتابخانه دیجیتال::
اداره علم سنجی::
ترجمان دانش::
اداره کتب و انتشارات ::
کتابخانه های تابعه::
کارگاه های توانمندسازی اعضای هیئت علمی::
آیین نامه ها و فرم ها::
اخبار و اطلاعیه ها::
کارگاه های مدیریت اطلاع رسانی::
تماس با ما::
مستندات علمی کرونا::
::
نظرسنجی
فعالیت سایت مدیریت اطلاع رسانی را چگونه ارزیابی می کنید؟
عالی
خوب
متوسط
ضعیف
   
..
:: مقالات علمی ::
 | تاریخ ارسال: 1399/1/30 | 
2. Macrolide treatment for COVID-19: Will this be the way forward?
3. TheItaliancoronavirusdisease2019outbreak: recommendationsfromclinicalpractic 
4. Non-steroidal anti-inflammatory drugs and covid-19 
5. Macrolide treatment for COVID-19: Will this be the way forward?
6. Chloroquine and hydroxychloroquine in covid-19
7.Diagnostic Value and Key Features of Computed Tomography in Coronavirus Disease 2019
8. Coronavirus: Update Related to the Current Outbreak of COVID-19 
9. meaCoronavirus(COVID-19):infectioncontroland prevention sures 
10. Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV) 
11. TurbulentGasCloudsandRespiratoryPathogenEmissions PotentialImplicationsforReducingTransmissionofCOVID-19 
12.  Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19
13.N95 Filtering Facepiece Respirator Ultraviolet Germicidal Irradiation (UVGI) Process for Decontamination and Reuse   
14. Commentary: COVID-19 in Patients with Diabetes 
 15. Potential therapeutic agents against COVID-19: What we know so far  
16. Recommendations for Endotracheal Intubation of COVID-19 Patients  
17. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
18. Special attention to nurses’ protection during the COVID-19 epidemic  
19. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review 
  20. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective  
 21.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths  
22. What Coronavirus Could Mean for the Global Economy 
 
دفعات مشاهده: 385 بار   |   دفعات چاپ: 45 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر
:: article ::
 | تاریخ ارسال: 1398/12/23 | 
1.COVID-19: too little, too late?
2.Pathological findings of COVID-19 associated with acute respiratory distress syndrome
3.Taking the right measures to control COVID-19
4. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) p
5.Essentials for Radiologists on COVID-19: An Update—Radiology Scientific Expert Panel
6.Return of the Coronavirus: 2019-nCoV
7.SARS to novel coronavirus – old lessons and new lessons
8.Transmission dynamics of 2019 novel coronavirus (2019-nCoV) --Manuscript Draft
9.Clinical characteristics of 5732 patients with 2019-nCoV infection --Manuscript Draft--
10. nderstanding of COVID-19 based on current evidence
11.Viral Shedding and Environmental Cleaning in Middle East Respiratory Syndrome Coronavirus Infection
دفعات مشاهده: 487 بار   |   دفعات چاپ: 29 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر
:: article ::
 | تاریخ ارسال: 1398/12/23 | 
1.TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection :Lack of TMPRSS2 affected the primary sites of infection and virus spread within the airway, accompanied by less severe immunopathology. However, TMPRSS2-KO mice showed weakened inflammatory chemokine and/or cytokine responses to intranasal stimulation with poly(I·C), a Toll-like receptor 3 agonist. In conclusion, TMPRSS2 plays a crucial role in viral spread within the airway of murine models infected by SARS-CoV and MERS-CoV and in the resulting immunopathology.
2. Occupational risks for COVID-19
3. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients 
4.Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia :Among the first 425 patients with confirmed NCIP, the median age was 59 years and 56% were male. The majority of cases (55%) with onset before January 1, 2020, were linked to the Huanan Seafood Wholesale Market, as compared with 8.6% of the subsequent cases. The mean incubation period was 5.2 days (95% confidence interval [CI], 4.1 to 7.0), with the 95th percentile of the distribution at 12.5 days. In its early stages, the epidemic doubled in size every 7.4 days. With a mean serial interval of 7.5 days (95% CI, 5.3 to 19), the basic reproductive number was estimated to be 2.2 (95% CI, 1.4 to 3.9).
5. Defining the Epidemiology of Covid-19 — Studies Needed
6. Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China
7.Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?
8. Pathogenicity and transmissibility of 2019-nCoVdA quick overview and comparison with other emerging viruses :the current knowledge in 2019-nCoV pathogenicity and transmissibility is summarized in comparison with several commonly known emerging viruses, and information urgently needed for a better control of the disease is highlighted.
9.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China 
10. The psychological impact of quarantine and how to reduce it: rapid review of the evidence
دفعات مشاهده: 470 بار   |   دفعات چاپ: 27 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر
:: article ::
 | تاریخ ارسال: 1398/12/23 | 
1. Clinical, Laboratory and Imaging Features of COVID-19: A systematic review and meta-analysis
2. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)
3. Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
4.Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
5. Coronavirus disease 2019: International public health considerations :This review describes the tenets of a public health response to an infectious outbreak by using recent historical examples and also by characterizing what is known about the ongoing response to the COVID-19 outbreak. The intent of the review is to empower the practitioner to monitor and evaluate the local, national and global public health response to an emerging infectious disease.
6. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From
the Chinese Center for Disease Control and Prevention
 

7.Clinical trial analysis of 2019‐nCoVtherapy registered inChina
8. Clinical trial analysis of 2019-nCoV therapy registered in China
9.Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection 
10. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective
دفعات مشاهده: 494 بار   |   دفعات چاپ: 31 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر
:: article ::
 | تاریخ ارسال: 1398/12/23 | 
1.Artificial Intelligence Forecasting of Covid-19 in China:We forecasted curves of cumulative confirmed cases of Covid-19 across China from Jan 20, 2020 to April 20, 2020. Using the multiple-step forecasting, the estimated average errors of 6-step, 7-step, 8-step, 9-step and 10-step forecasting were 1.64%, 2.27%, 2.14%, 2.08%, 0.73%, respectively. We predicted that the time points of the provinces/cities entering the plateau of the forecasted transmission dynamic curves varied, ranging from Jan 21 to April 19, 2020. The 34 provinces/cities were grouped into 9 clusters. 
2. Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2: The results revealed that naringin may have a potential application for preventing cytokine storm. We simulated molecular docking to predict the binding affinity of those flavonoids to bind Angiotensin-converting enzyme 2 (ACE 2), which is a receptor of the coronavirus. Consideration of the potential anti-coronavirus and anti-inflammatory activity of flavonoids, the citrus fruit or its derived phytochemicals are promising in the use of prevention and treatment of 2019-nCoV infection.
3. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies :More comprehensive information is required to understand 2019-nCoV feature, the epidemiology of origin and spreading, and the clinical phenomina. According to the current status, blocking transmission, isolation, protection, and alternative medication are the urgent management strategies against 2019-nCoV.
4.A strategy to prevent future epidemics similar to the 2019-nCoV outbreak :To prevent the next epidemic and pandemic related to these interfaces, we call for research and investment in three areas: 1) surveillance among wildlife to identify the high-risk pathogens they carry; 2) surveillance among people who have contact with wildlife to identify early spillover events; and 3) improvement of market biosecurity regarding the wildlife trade.

5. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
6. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series: As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.
7. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study​: Compared with the cases in Wuhan, 80 imported cases of COVID-19 in Jiangsu Province exhibited mild or moderate symptoms and no obvious gender susceptivity, lower proportion of liver dysfunction and abnormal CT imaging and higher frequency nucleic acid detection
8. Clinical characteristics of 82 death cases with COVID-19 : Older males with comorbidities are more likely to develop severe disease, even die from SARS-CoV-2 infection. Respiratory failure is the main cause of COVID-19, but either virus itself or cytokine release storm mediated damage to other organ including cardiac, renal, hepatic, and hemorrhage should be taken seriously as well.
9. Clinical Characteristics of Coronavirus Disease 2019 in China 
10. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV- 2 infection in Wuhan, China: A retrospective single center analysis 
دفعات مشاهده: 505 بار   |   دفعات چاپ: 25 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر
برای مشاهده کل مطالب بخش مقالات علمی اینجا را کلیک کنید.